ロード中...

Imatinib improves insulin resistance and inhibits injury-induced neointimal hyperplasia in high fat diet-fed mice

Imatinib, a PDGF receptor tyrosine kinase inhibitor, has been shown to suppress intimal hyperplasia in different animal models under normal metabolic milieu, diabetic, and/or hypercholesterolemic conditions. However, the impact of imatinib treatment on injury-induced neointimal hyperplasia has not y...

詳細記述

保存先:
書誌詳細
出版年:Eur J Pharmacol
主要な著者: Pichavaram, Prahalathan, Shawky, Noha M., Hartney, Thomas J., Jun, John Y., Segar, Lakshman
フォーマット: Artigo
言語:Inglês
出版事項: 2020
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7749815/
https://ncbi.nlm.nih.gov/pubmed/33131722
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejphar.2020.173666
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!